Role of SHP-2 tyrosine phosphatase in the DNA damage-induced cell death response

J Biol Chem. 2003 Apr 25;278(17):15208-16. doi: 10.1074/jbc.M211327200. Epub 2003 Feb 19.

Abstract

SHP-2, a ubiquitously expressed Src hmology 2 (SH2) domain-containing tyrosine phosphatase, plays a critical role in the regulation of growth factor and cytokine signal transduction. Here we report a novel function of this phosphatase in DNA damage-induced cellular responses. Mutant embryonic fibroblast cells lacking functional SHP-2 showed significantly decreased apoptosis in response to DNA damage. Following cisplatin treatment, induction of p73 and its downstream effector p21(Cip1) was essentially blocked in SHP-2 mutant cells. Further investigation revealed that activation of the nuclear tyrosine kinase c-Abl, an essential mediator in DNA damage induction of p73, was impaired in the mutant cells, suggesting a functional requirement of SHP-2 in c-Abl activation. Consistent with this observation, the effect of overexpression of c-Abl kinase in SHP-2 mutant cells on sensitizing the cells to DNA damage-induced death was abolished. Additionally, we found that in embryonic fibroblast cells 30-40% of SHP-2 was localized in the nuclei, and that a fraction of nuclear SHP-2 was constitutively associated with c-Abl via its SH3 domain. Phosphatase activity of nuclear but not cytoplasmic SHP-2 was significantly enhanced in response to DNA damage. These results together suggest a novel nuclear function for SHP-2 phosphatase in the regulation of DNA damage-induced apoptotic responses.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Cisplatin / pharmacology
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / biosynthesis
  • DNA Damage*
  • DNA-Binding Proteins / biosynthesis
  • Embryo, Mammalian / cytology
  • Fibroblasts / cytology
  • Fibroblasts / enzymology
  • Gene Expression Regulation / drug effects
  • Genes, Tumor Suppressor
  • Intracellular Signaling Peptides and Proteins
  • Mice
  • Mice, Knockout
  • Mutagens / pharmacology
  • Nuclear Proteins / biosynthesis
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Nuclear Proteins / physiology
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases / genetics
  • Protein Tyrosine Phosphatases / metabolism
  • Protein Tyrosine Phosphatases / physiology*
  • Proto-Oncogene Proteins c-abl / metabolism
  • SH2 Domain-Containing Protein Tyrosine Phosphatases
  • Signal Transduction
  • Tumor Protein p73
  • Tumor Suppressor Proteins

Substances

  • Cdkn1a protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • DNA-Binding Proteins
  • Intracellular Signaling Peptides and Proteins
  • Mutagens
  • Nuclear Proteins
  • Trp73 protein, mouse
  • Tumor Protein p73
  • Tumor Suppressor Proteins
  • Proto-Oncogene Proteins c-abl
  • Protein Tyrosine Phosphatase, Non-Receptor Type 11
  • Protein Tyrosine Phosphatases
  • Ptpn11 protein, mouse
  • SH2 Domain-Containing Protein Tyrosine Phosphatases
  • Cisplatin